XML 41 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Apr. 16, 2026
Jun. 05, 2025
Sep. 27, 2022
Apr. 06, 2022
Oct. 18, 2021
Feb. 28, 2026
Nov. 30, 2025
May 31, 2025
Feb. 29, 2024
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 03, 2026
Jun. 02, 2026
Dec. 31, 2025
Stockholders Equity [Line Items]                                
Common stock, shares authorized                   400,000,000   400,000,000   400,000,000 200,000,000 200,000,000
Stock issuance cost                       $ 445 $ 590      
Share based compensation options grants in the period                       3,581,500        
Common Stock, Shares, Outstanding                   142,420,883   142,420,883       128,306,056
Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period                   13,340,000 20,010,000 13,340,000 20,010,000      
Performance-Based Vesting Stock Options [Member]                                
Stockholders Equity [Line Items]                                
Share based compensation options grants in the period           710,500     832,250              
Share-based compensation options vested (in shares)               642,160                
Private Placement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Common Stock, Shares, Outstanding                   12,531,332   12,531,332        
Private Placement [Member] | New Enterprise Associates 16, L.P [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock         3,703,704                      
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period         1,851,852                      
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                                
Stockholders Equity [Line Items]                                
Common stock warrants exercise price and expiration date description                       The accompanying common stock warrants have an exercise price of $1.37 per share and became exercisable immediately upon issuance. Of the accompanying common stock warrants, warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock were scheduled to expire on April 18, 2025, and warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on October 18, 2028. On April 17, 2025, NEA exercised all of the warrants that would have expired on April 18, 2025. None of the accompanying common stock warrants issued to NEA in the private placement that expire on October 18, 2028 have been exercised.        
Combined price of each shares         $ 1.62                      
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs         $ 3,000                      
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock Warrants                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock         1,851,852                      
Exercise price per share of warrants         $ 1.37                      
Warrants expiration date         Apr. 18, 2025                      
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Warrant [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock         1,851,852                      
Warrants expiration date         Oct. 18, 2028                      
Private Placement [Member] | Securities Purchase Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period       4,580,526                        
Combined price of each shares       $ 1.90                        
Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Combined price of each shares       $ 1.899                        
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs       $ 55,000                        
Exercise price per share of warrants       $ 0.001                        
September 2022 Offering [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Common Stock, Shares, Outstanding                   4,717,616   4,717,616        
September 2022 Offering [Member] | Underwriting Agreement [Member]                                
Stockholders Equity [Line Items]                                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs     $ 58,100                          
Warrants initial closing date     Sep. 27, 2022                          
September 2022 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period     14,252,670                          
Combined price of each shares     $ 1.93                          
Exercise price per share of warrants     $ 0.001                          
September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock     14,247,330                          
Combined price of each shares     $ 1.929                          
Options to purchase additional shares     1,600,428                          
April 2026 Offering [Member] | Underwriting Agreement [Member]                                
Stockholders Equity [Line Items]                                
Aggregate gross proceeds $ 173,400                              
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs $ 162,300                              
April 2026 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period 11,600,000                              
Combined price of each shares $ 13                              
June 2025 Offering [Member] | Underwriting Agreement [Member]                                
Stockholders Equity [Line Items]                                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs   $ 115,100                            
June 2025 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Sale of stock during the period   17,400,000                            
Combined price of each shares   $ 5.75                            
Maximum [Member] | Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock       24,379,673                        
Maximum [Member] | September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock     4,275,000                          
Maximum [Member] | April 2026 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock 1,740,000                              
Maximum [Member] | June 2025 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                                
Stockholders Equity [Line Items]                                
Warrants to purchase aggregate shares of common stock   2,610,000                            
Common Stock Purchase Agreement [Member]                                
Stockholders Equity [Line Items]                                
Aggregate offering price of common stock which may issue and sell under agreement             $ 200,000                  
Sale of stock during the period                       0